IGFBP5 and lung carcinoma: In lung cancer, IGFBP5 counteracted RASSF1C-induced ERK1/2-dependent stimulation of the stem cell gene Piwi like RNA-mediated gene silencing 1 (PIWIL1) resulting in re-sensitization of tumor cells to the anti-cancer drug betulinic acid (91).